Yu, Xueqing

Adjunct Professor

Education Background

MD,PhD(Sun Yat-sen University  of Medical science)

Research Field
Bio-marker prediction and treatment of CKD, Peritoneal dialysis ,Precision research of Immunonephropathy including IgA nephropathy and lupus nephritis

Prof. Yu Xueqing currently serves as the president of Guangdong Provincial People’s Hospital/Guangdong Academy of Medical Sciences. He holds academic positions including president of International Society for Peritoneal Dialysis, Executive member of Asian-Pacific Society of Nephrology and Chair of CME committee, President of Asian Renal Association, Editor board member of American Journal Kidney Diseases and subject editor of Nephrology. He undertakes 46 scientific research funds. He is the winner of 9 prizes including 1 second prize National Sci-Tech Advance Award, 1 Sci-Tech Progress Award of the Ministry of Education, and 1 first prize of the Natural Science of Guangdong province. He has published 443 scientific papers, among which 181 were indexed by SCI, including Nature GeneticsNature CommunicationsCell MetabolismScience Translational Medicine and etc. He has published 17 academic monographs, including 8 chief editors .Prof. Yu established a Peritoneal Dialysis Center with world leading patient survival and technical survival rates, The prestigious academic journal Lancet describes him as “a driving force in Chinese nephrology”.

Academic Publications

Selected Publications:

1.  Xu R, Li Q, Yu XQ(2017).Association Analysis of the MHC in Lupus Nephritis. J Am Soc Nephrol. 28:3383-3394 PMID:28754791
2. Ai Z, Li M, Yu XQ (2016).Low α-defensin gene copy number increases the risk for IgA nephropathy and renal dysfunction.Sci Transl Med. 8:345ra88.PMID:27358498
3. Li M, Foo JN, Yu XQ,(2015). Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun. 6:7270. PMID:26028593
4.  Yu XQ, Li M, Zhang H, et al  (2012). A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet. 44:178-82. PMID:22197929
5. Li M, Yu XQ(2018). Genetic study of immunoglobulin A nephropathy: From research to clinical application. Nephrology. 23. PMID:30298665
6. Xu R, Li Q, , Yu XQ(2017).Association Analysis of the MHC in Lupus Nephritis. J Am Soc Nephrol. 28:3383-3394 PMID:28754791
7. Zhang L, Li J, Yang S, Huang N, Zhou Q, Yang Q,Yu X (2016). Clinicopathological features and risk factors analysis of IgA nephropathy associated with acute kidney injury. Ren Fail. 38:799-805. PMID:27050722
8.  Ouyang CJ, Huang FX, Yu XQ(2015). Comparing the Incidence of Catheter-Related Complications with Straight and Coiled Tenckhoff Catheters in Peritoneal Dialysis Patients-A Single-Center Prospective Randomized Trial. Perit Dial Int. 35:443-449. PMID:24584608
9. Xia X, He F, Yu XQ(2014). Relationship Between Serum Uric Acid and All-Cause and Cardiovascular Mortality in Patients Treated With Peritoneal Dialysis.Am J Kidney Dis. 64:257-264. PMID:24176223.
10. Chen W, Liu Q, Yu XQ(2012). Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus. 21: 944-952. PMID:22438027.
11. Chen W, Tang X, Yu XQ(2011). Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.Am J Kidney Dis. 57: 235-244. PMID:21177013.
12. Zhou Y, Mao HP, Yu XQ(2010). HSP72 Inhibits Smad3 Activation and Nuclear Translocation in Renal Epithelial-to-Mesenchymal Transition. J Am Soc Nephrol. 21: 598-609 .PMID:20133478.